CoChat

Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients

Ng, Brendan J., Le Couteur, David G., Hilmer, Sarah N. · 2018 · Drugs & Aging

The DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.

Abstract

Benzodiazepines (BZDs; including the related Z-drugs) are frequently targets for deprescribing; long-term use in older people is harmful and often not beneficial. BZDs can result in significant harms, including falls, fractures, cognitive impairment, car crashes and a significant financial and legal burden to society. Deprescribing BZDs is problematic due to a complex interaction of drug, patient, physician and systematic barriers, including concern about a potentially distressing but rarely fatal withdrawal syndrome. Multiple studies have trialled interventions to deprescribe BZDs in older people and are discussed in this narrative review. Reported success rates of deprescribing BZD interventions range between 27 and 80%, and this variability can be attributed to heterogeneity of methodological approaches and limited generalisability to cognitively impaired patients. Interventions targeting the patient and/or carer include raising awareness (direct-to-consumer education, minimal interventions, and 'one-off' geriatrician counselling) and resourcing the patient (gradual dose reduction [GDR] with or without cognitive behavioural therapy, teaching relaxation techniques, and sleep hygiene). These are effective if the patient is motivated to cease and is not significantly cognitively impaired. Interventions targeted to physicians include prescribing interventions by audit, algorithm or medication review, and providing supervised GDR in combination with medication substitution. Pharmacists have less frequently been the targets for studies, but have key roles in several multifaceted interventions. Interventions are evaluated according to the Behaviour Change Wheel. Research supports trialling a stepwise approach in the cognitively intact older person, but having a low threshold to use less-consultative methods in patients with dementia. Several resources are available to support deprescribing of BZDs in clinical practice, including online protocols.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40266-018-0544-4

Cites

159 of 159 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Research works printed but not linked: 3

  1. Hatton J. Fear of falling and its relationship to depression and anxiety in older adults living in the community and in extended care facilities in Australia [professional Doctorate]. Perth: Murdoch University; 2016.
  2. Petrovic M, Pevernagie D, Van Den Noortgate N, Mariman A, Michielsen W, Afschrift M. A program for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: Success rate and effect on subjective sleep quality. Int J Geriatr Psychiatry. 1999;14(9):754–60. · doi:10.1002/(sici)1099-1166(199909)14:9<754::aid-gps15>3.0.co;2-e
  3. Towle I, Adams J. A novel, pharmacist-led strategy to reduce the prescribing of benzodiazepines in Paisley. Pharm J. 2006;276(7386):136–8.

Cited by

See all 119

Metadata

Authors
Ng, B. J., Le Couteur, D. G., & Hilmer, S. N.
Affiliations
The University of Sydney (AU)
Corresponding author
Hilmer, Sarah N.
Venue
Drugs & Aging
Published
2018-04-28
Volume
35
Issue
6
Pages
493-521
ISSN
  • 1170-229X (ISSN-L)
  • 1179-1969
OpenAlex
W2800093210
Cited by
118
References
160
Citations by year
2026: 9 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 23 · 2021: 22 · 2020: 11 · 2019: 14 · 2018: 2
FWCI
1.38
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Drugs & Aging (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ageing and Alzheimers Institute
  • Penney Ageing Research Unit
  • New South Wales Health Translational Research Grants Scheme (TRG274)
  • Australian and New Zealand Society for Geriatric Medicine
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
benzodiazepine deprescribing, older adults, Z-drugs, gradual dose reduction, cognitive behavioral therapy, sleep hygiene, prescribing interventions, pharmacist intervention, medication review, Behaviour Change Wheel, dementia, withdrawal syndrome, falls and fractures, cognitive impairment
MeSH terms
Deprescriptions, Age Factors, Attitude of Health Personnel, Benzodiazepines, Geriatrics, Humans, Pharmacists, Physicians, Drug Prescriptions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.